Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Trinity Biotech plc

Trinity Biotech plc (TRIB) Stock Overview

Explore Trinity Biotech plc’s financial performance, market position, analyst ratings, and future outlook.

TRIB●NASDAQ
HealthcareMedical - Diagnostics & Research
$10.78
$0.22(2.000%)
U.S. Market opens in 13h 59m

Trinity Biotech plc (TRIB)

Meyka AI Score

Z

Key Financials

Market Cap215.5M
P/E Ratio-0.18
EPS (TTM)$-3.85
ROE0.68%
Fundamental Analysis

AI Price Forecasts

1 Month$13.47
3 Months$1.98
1 Year Target$0.26

TRIB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Trinity Biotech plc (NASDAQ: TRIB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Trinity Biotech plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TRIB on the NASDAQ shows an RSI of 70.39, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.26 for the NASDAQ listing.

Key metrics behind Trinity Biotech plc's NASDAQ-traded stock include a P/E ratio of -0.18 and a market capitalization of 215.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TRIB on the NASDAQ.

Price Performance (NASDAQ: TRIB)

1-Day Change
-3.27%
5-Day Change
-15.82%
1-Month Change
-12.64%
3-Month Change
-41.05%
6-Month Change
-49.88%
Year-to-Date (YTD) Change
-55.16%
1-Year Change
-60.59%
3-Year Change
-91.13%
5-Year Change
-96.97%
All-Time (Max) Change
-99.56%

Contact Information

https://www.trinitybiotech.com
353 1 276 9800
IDA Business Park, Bray, WW, A98 H5C8

Company Facts

2,870 Employees
IPO DateOct 21, 1992
CountryIE
Actively Trading

Frequently Asked Questions